Medifast, Inc. MED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -27.64% | -34.29% | -36.90% | -36.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -27.64% | -34.29% | -36.90% | -36.21% |
| Cost of Revenue | -- | -20.49% | -22.85% | -25.43% | -- |
| Gross Profit | -- | -30.33% | -38.56% | -40.90% | -- |
| SG&A Expenses | -- | -25.72% | -33.49% | -20.03% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -24.30% | -30.32% | -21.64% | -32.28% |
| Operating Income | -- | -305.91% | -334.15% | -159.06% | -293.78% |
| Income Before Tax | -- | -204.03% | -469.01% | -600.55% | -- |
| Income Tax Expenses | -- | -72.41% | -86.06% | 2,376.16% | -- |
| Earnings from Continuing Operations | -- | -225.00% | -174.87% | -2,362.05% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -225.00% | -174.87% | -2,362.05% | -300.27% |
| EBIT | -- | -305.91% | -334.15% | -159.06% | -293.78% |
| EBITDA | -- | -129.57% | -198.91% | -126.46% | -111.87% |
| EPS Basic | -661.35% | -223.40% | -173.48% | -2,352.05% | -299.32% |
| Normalized Basic EPS | -559.76% | -202.69% | -3,898.28% | -146.10% | -267.52% |
| EPS Diluted | -647.62% | -227.27% | -173.48% | -2,458.37% | -310.00% |
| Normalized Diluted EPS | -559.76% | -203.32% | -3,898.28% | -146.29% | -268.08% |
| Average Basic Shares Outstanding | 1.73% | 1.31% | 0.53% | 0.48% | 0.49% |
| Average Diluted Shares Outstanding | 1.73% | 0.68% | 0.53% | 0.07% | 0.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -67.44% | 0.84% | -- | -1.00% |